SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

UBS Sees Potential Upside From Two ALX Oncology Clinical Readouts

UBS says ALX Oncology is approaching two clinical catalysts.

ALXO

Related stories